Analyst Ratings for Arcus Biosciences (RCUS)
RCUS Rating Summary
RCUS Price Target Summary
- Highest: $47.00 (Leerink)
- Lowest: $23.00 (Morgan Stanley)
- Average: $36.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$36.60 (+65.5%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
Avg. $ Target:
$36.60 (+65.5%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/16/2026 | William Blair | Alethia Young | New Coverage | Outperform (N/A) |
N/A (N/A) |
22.53 (22.12) |
-1.82% | Details |
| 10/14/2026 | JPMorgan | Priyanka Grover | New Coverage | Overweight (N/A) |
41.00 (N/A) |
24.34 (22.12) |
-9.12% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
